![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19498-19505, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Section on Metabolic Regulation, Endocrinology and
Reproduction Research Branch, NICHD, National Institutes of
Health, Bethesda, Maryland 20892-4510
Received for publication, September 20, 2001, and in revised form, March 18, 2002
Neurogranin (Ng) is a brain-specific,
postsynaptically located protein kinase C (PKC) substrate, highly
expressed in the cortex, hippocampus, striatum, and amygdala. This
protein is a Ca2+-sensitive calmodulin (CaM)-binding
protein whose CaM-binding affinity is modulated by phosphorylation and
oxidation. To investigate the role of Ng in neural function, a strain
of Ng knockout mouse (KO) was generated. Previously we reported (Pak,
J. H., Huang, F. L., Li, J., Balschun, D., Reymann, K. G., Chiang, C., Westphal, H., and Huang, K.-P. (2000) Proc. Natl.
Acad. Sci. U. S. A. 97, 11232-11237) that these KO mice
displayed no obvious neuroanatomical abnormality, but exhibited
deficits in learning and memory and activation of
Ca2+/CaM-dependent protein kinase II. In this
report, we analyzed several downstream phosphorylation targets in
phorbol 12-myristate 13-acetate- and forskolin-treated hippocampal
slices from wild type (WT) and KO mice. Phorbol 12-myristate 13-acetate
caused phosphorylation of Ng in WT mice and promoted the translocation of PKC from the cytosolic to the particulate fractions of both the WT
and KO mice, albeit to a lesser extent in the latter. Phosphorylation of downstream targets, including mitogen-activated protein kinases, 90-kDa ribosomal S6 kinase, and the cAMP response element binding protein (CREB) was significantly attenuated in KO mice. Stimulation of
hippocampal slices with forskolin also caused greater stimulation of
protein kinase A (PKA) in the WT as compared with those of the KO mice.
Again, phosphorylation of the downstream targets of PKA was attenuated
in the KO mice. These results suggest that Ng plays a pivotal role in
regulating both PKC- and PKA-mediated signaling pathways, and that the
deficits in learning and memory of spatial tasks detected in the KO
mice may be the result of defects in the signaling pathways leading to
the phosphorylation of CREB.
Neurogranin (Ng)1 is a
brain-specific, Ca2+-sensitive calmodulin (CaM)-binding
phosphoprotein, and is highly expressed in the neuronal cell bodies and
dendrites within the hippocampus, neocortex, amygdala, and striatum
(1-5). Ng is a specific substrate of protein kinase C (PKC), and it
can also be modified by nitric oxide and other oxidants to form
intramolecular disulfide (6-9). Both the phosphorylation and oxidation
of Ng attenuate its binding affinity for CaM (7, 9-11). To investigate
the role of Ng in neural function, a strain of Ng knockout mouse (KO)
was generated (12). These mutant mice displayed no obvious
neuroanatomical abnormality; however, they exhibited deficits in
learning the spatial tasks when tested with Morris water maze. In
addition, Ca2+/CaM-dependent protein kinase II
(CaMKII) in the hippocampal slices of these KO mice is less readily
autophosphorylated as compared with those of the wild type (WT) mice
upon treatments that enhance Ng phosphorylation and oxidation.
Induction of hippocampal long term potentiation (LTP, an experimental
model of learning and memory) is well recognized to be initiated by the
stimulation of N-methyl-D-aspartate receptor, and perhaps also metabotropic glutamate receptors, and is dependent on
the influx of Ca2+ through
N-methyl-D-aspartate receptors as well as
voltage-dependent calcium channel. Subsequently, the
expression and the maintenance of LTP and the eventual consolidation
and storage of information into the long term memory are known to
depend on the stimulation of several Ca2+/CaM-sensitive
enzymes (including CaMKII), PKC, protein kinase A (PKA), and other
kinases in the phosphorylation cascade, and eventual de novo
protein synthesis (13-17). Judging from its CaM-binding property, Ng
would have assumed a fairly upstream regulatory role in the biochemical
mechanisms involved in the memory formation.
Mitogen-activated protein kinase (MAP kinase), also known as
extracellular signal-regulated kinase, is a family of serine/threonine protein kinases having widespread distributions. MAP kinase cascade was
originally discovered as a critical regulator of cell division and
differentiation (18-20). Interestingly, MAP kinase signaling cascades
were discovered also to play a pivotal role in synaptic plasticity and
learning and memory (16, 21-27). Moreover, many studies indicated that
signal transductions lead to activation of either PKC or PKA can elicit
hippocampal MAP kinase activation, and MAP kinase is an important
regulator of cAMP response element-binding protein (CREB)
phosphorylation in the hippocampus (15, 22, 24, 28). Some of these
studies (15, 22, 29) also show that 90-kDa ribosomal S6 kinase (RSK2)
is a likely candidate coupling MAP kinase to CREB phosphorylation.
RSK2, which is directly activated by MAP kinase via phosphorylation, in
turn phosphorylates CREB at Ser-133 and thereby regulates its activity
as a transcriptional activator. In light of its unique CaM-binding
ability in the absence of Ca2+, Ng generally can be
considered as a CaM depot. Upon activation of glutamatergic neurons,
the rising intracellular Ca2+ would be expected to displace
Ng from the CaM/Ng complex, and the resulting Ca2+/CaM
became available for the various
Ca2+/CaM-dependent enzymes, these in turn
regulate the downstream targets including those in the aforementioned
MAP kinase cascade. In the absence of Ng, as in the KO mice, lack of
the CaM depot will lead to the perturbation of most, if not all, of
these signaling steps.
In the present study, we analyzed several downstream phosphorylation
components in responding to phorbol 12-myristate 13-acetate (PMA) and
forskolin in the hippocampal slices of both WT and KO mice. The results
show that both PKC and PKA are activated to greater degrees by PMA and
forskolin, respectively, in the WT than those of KO mice. Consequently,
the activation of downstream signaling components, including MAP
kinases, p90RSK, and CREB, are greatly attenuated in KO as compared
with the WT mice. These results, together with our previous observation
of the defect of CaMKII autophosphorylation in the KO mice, strongly
support the notion that Ng plays an important role in neuronal signal transductions. As a result of genetic knockout of Ng, many defects including those reported presently render the mutant mice poorer learners as compared with WT mice. These Ng KO mice will be a useful
model to delineate the signal transduction pathways in the
hippocampus-dependent memory acquisition, storage, and retrieval.
Materials--
The following materials were obtained from the
indicated sources: PMA, LC Laboratories; forskolin, Alexis
Biochemicals; Ng peptide (residues 28-43) and
Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide), Bachem Inc.; PKA inhibitor
peptide (residues 5-22), SynPep Corp.; [ Preparation and Treatment of Mouse Hippocampal
Slices--
Hippocampi from adult mouse brain (3-4 months old) were
removed immediately after decapitation and placed into ice-cold
artificial cerebrospinal fluid (ACSF, in mM: NaCl 125, KCl
2.5, CaCl2 2.0, NaHCO3 26, NaH2PO4 1.25, MgCl2 1.0, glucose
25) bubbling with 95% O2, 5% CO2. Transverse
hippocampal slices (400 µm) were prepared with a McIlwain tissue
chopper and incubated in ACSF in a chamber saturated with 95%
O2, 5% CO2 at room temperature for at least 3 h before treatment. Hippocampal slices (5-6 slices each) from either WT or KO mice were treated with 4 µM PMA or 50 µM forskolin in ACSF for the indicated times, and the
tissues were washed and kept frozen at Preparation of Cytosolic and Particulate Fractions and PKC
Assay--
Frozen slices (6-7 slices) were rapidly thawed and
homogenized at 4 °C in 100 µl of Buffer A (Homogenization Buffer
without SDS, but with 5 mM sodium pyrophosphate).
Homogenates were centrifuged at 100,000 × g for 30 min
at 4 °C in a OptimaTM TLX Ultracentrifuge to yield cytosol. The
pellet fractions were resuspended in 100 µl of Buffer A containing
0.5% Nonidet P-40, sonicated, and centrifuged again. The resulting
supernatants, taken as the particulate fractions, together with the
cytosolic fractions, were assayed for PKC activities and immunoreactivities.
PKC activity was determined in both the cytosolic and particulate
fractions as previously described (30). Briefly, measurement was at
30 °C for 5 min in a mixture (25 µl) containing 30 mM
Tris-Cl (pH 7.5), 6 mM MgCl2, 120 µM [ Protein Kinase A Assay--
Hippocampal slices (4-5 slices)
were homogenized and briefly sonicated on ice in 120 µl of Buffer A
containing 0.1% Nonidet P-40. Homogenates were centrifuged at
20,800 × g for 5 min at 4 °C. The supernatant was
used for protein determination and PKA assay. PKA activity was measured
at 30 °C for 5 min in a mixture (25 µl) containing 30 mM Tris-Cl (pH 7.5), 6 mM MgCl2,
120 µM [
Throughout the study, protein concentrations were determined by the
Bradford method (31) with bovine serum albumin as standard.
Immunoblotting--
For MAP kinase, RSK2, and CREB blots, 30 µg of protein from each sample was loaded per lane for SDS-PAGE (10%
gel). For PKC and Ng, 20 µg of protein was used for electrophoresis
in SDS-PAGE (8 and 10-20% gradient gels, respectively). After
electrophoresis and transfer of proteins onto nitrocellulose membrane
at 4 °C, the membrane was washed for 10 min with TTBS (20 mM Tris-Cl, pH 7.5, containing 0.15 M NaCl, and
0.05% Tween 20), blocked with 5% nonfat dried milk in TTBS for 40 min, washed three times with TTBS, and then incubated with primary and
secondary antibodies in TTBS, consecutively, for 3-4 and 1 h, respectively.
For phospho-MAP kinase, an anti-dual phospho-MAP kinase monoclonal
antibody (Cell Signaling Technology; selectively detects doubly
phosphorylated Thr-202 and Tyr-204 of p44 and p42 MAP kinases) was used
at 1:1000 dilution. In this and all other Western blot protocols
described below, the blots were washed extensively in TTBS after
incubations with primary and second antibodies (typically three washes,
each for 10 min). For monoclonal antibodies, horseradish peroxidase-conjugated goat anti-mouse IgG was used as secondary antibody; for polyclonal antibodies, horseradish peroxidase-conjugated goat anti-rabbit IgG was used. Both were used at 1:5000 dilution. Signals were revealed via enhanced chemiluminescence reagent (ECL, PerkinElmer Life Sciences).
For phospho-RSK2, we used two different primary antibodies specific for
two separate phosphorylation sites, phospho-p90RSK Ser-380 (Upstate
Biotechnology, Inc.) and Thr-360/Ser-364 (Cell Signaling Technology).
For phospho-CREB, the primary antibody (diluted 1:1000, Cell Signaling
Technology) detects CREB only when activated by phosphorylation at
Ser-133. For total MAP kinase and total CREB immunoreactivities, those
membranes previously blotted with phosphorylation-dependent
antibodies were stripped using buffer containing 62.5 mM
Tris-Cl, pH 6.7, 100 mM 2-mercaptoethanol, and 2% SDS for
30-60 min at 55 °C with constant shaking. The blots were washed
several times and re-blocked, and treated the same way as for the
phosphospecific antibody. Both total MAP kinase antibodies (New England
Biolabs), recognize both p44 and p42 MAP kinases, and total CREB
antibodies are phosphorylation state-independent and were used at
1:1000 dilution.
For PKC, an anti-conventional PKC antibodies previously prepared in our
laboratory (32) was used at 1:3000 dilution. Use of antibodies 3615 and
270 for the detection of phosphorylated and total Ng were as described
previously (6, 8, 12).
Data Analysis--
The data were expressed as mean ± S.E.
of at least three independent experiments when using KO mice, where the
responses elicited by the various treatments were minimal, and of five
to six independent experiments using WT mice. Quantitative analysis for
immunoblot was done by scanning the x-ray film and determined using the
Fotodyne Gel-Pro Analyzer program. Statistical analysis was conducted
by one-way analysis of variance followed by paired comparisons using Student's t test.
Deletion of Ng Causes Different Kinetics of PMA-mediated PKC
Activation--
Under control conditions, specific PKC activities
determined in the cytosolic (S) and particulate membrane (P) fractions
of WT and KO mice hippocampal slices were, respectively, 188 ± 27.4 (WT, S, n = 7), 173 ± 9.3 (KO, S,
n = 4), 155 ± 11.8 (WT, P, n = 7), and 145 ± 10.0 (KO, P, n = 4) pmol/µg of
protein/5 min. Exposure of these hippocampal slices to PMA, a PKC
activator, caused an apparent translocation of protein kinase C
activity from the cytosolic to the particulate membrane fractions (Fig. 1B). Brief (2-min) incubation
with 4 µM PMA resulted in a rapid decrease in the
cytosolic PKC activity, and the reduction of cytosolic PKC in the WT
was significantly greater than that of the KO (80 ± 4.7% (WT, S,
n = 7) versus 91 ± 8.2% (KO, S,
n = 4), p < 0.05). After 5 min of
incubation, PKC activity in the cytosolic fraction of WT mice slightly
recovered, but then decreased continuously until the end of incubation
at 60 min. In contrast, in the KO mice, there was a slow decrease of
PKC activity in cytosolic fraction. At 60 min, the remaining level of
cytosolic PKC in the WT was much less than that of the KO mice (53 ± 6.4% (WT, S, n = 7) versus 71 ± 14.0% (KO, S, n = 4), p < 0.05). On
the other hand, in the particulate membrane fractions, at 2 min, the
translocated PKC activity is significantly higher in the WT mice than
that in the KO mice (percentage of control values, 126 ± 6.0%
(WT, P, n = 7) versus 111 ± 12.1%
(KO, P, n = 4), p < 0.05). For the WT,
after an initial increase in the activity of the particulate fraction at 2 min, there was a slight dip at 5 min, and then the level immediately increased after 10 min until the end of incubation. In
contrast, there was only a small and slow increase of PKC activity in
the particulate fractions of KO mice. The level of particulate PKC in
the KO at 60 min was significantly less than that of the WT mice
(118 ± 16.3% (KO, P, n = 4) versus
140 ± 11.2% (WT, P, n = 7), p < 0.05). The data suggested that the degree of translocation of PKC in
the KO is less than that of the WT mice. The immunoblot analysis with a
conventional PKC antibody (Fig. 1A) supported this
conclusion.
PMA Induces Ng Phosphorylation in Hippocampal Slices of WT
Mice--
Ng has been shown to be a specific PKC substrate. As PMA
treatment promotes the translocation and activation of PKC in
hippocampal slices (Fig. 1), it is of interest to test the status of Ng
phosphorylation during PMA treatment. Fig.
2A (top
panel) shows that 4 µM PMA, the concentration
used in the previous PKC translocation experiment, induced a
time-dependent phosphorylation of Ng determined by
immunoblot analysis with antibodies specific for phosphorylated Ng. It
reached a maximal level in 10 min and declined slightly afterward until the end of incubation at 60 min (Fig. 2B). Degrees of Ng
phosphorylation at 2, 5, 10, 30, and 60 min were, respectively,
135 ± 5.5, 148 ± 11.3, 157 ± 11.4, 129 ± 9.9,
and 127 ± 13.5% of basal level (p < 0.001).
Total Ng levels were unchanged by the above treatments (Fig.
2A, bottom panel), as shown in the
immunoblot analyses with antibodies independent of phosphorylation
state of Ng. These results demonstrate that the phosphorylation of Ng
does occur in the neurons when PKC is activated either directly by PMA
(present study) or indirectly by
carbachol.2 Needless to say,
such reaction does not take place in the KO mice, as Ng is completely
devoid in these mice.
Ng KO Mice Exhibit Lesser Degree of Activation of MAP Kinase
Cascades--
It was reported that PKC activation in hippocampal
slices resulted in an activation of mostly p42 MAP kinase, an effect
that has been observed in a wide variety of cell types (16, 33, 34). In
the present studies we found that PMA elicited activation of both p44
and p42 MAP kinases. Fig. 3A
(left panels) showed that, in hippocampal slices
of WT mice, 4 µM PMA produced a rapid increase in
immunoreactivities of phospho-MAP kinases within 2 min of stimulation;
the phosphorylation and activation remained high and only declined to
near basal level after 60 min of incubation. In contrast, the same
concentration of PMA did not induce much increase in MAP kinase
phosphorylation in Ng KO mice (Fig. 3A, right
panels). After 2, 5, 10, and 30 min of incubations,
activations of p42 MAP kinase in WT mice were averaged 1.4-1.9-fold
greater than those of the KO mice (percentages of control values were, for WT, 171 ± 16.9%, 2 min; 190 ± 24.7%, 5 min; 204 ± 22.2%, 10 min; and 162 ± 29.8%, 30 min; n = 6; and for KO, 100.3 ± 0.9%, 2 min; 107 ± 2.7%, 5 min;
110 ± 1.2%, 10 min; and 114 ± 1.8%, 30 min;
n = 3, p < 0.05) (Fig. 3B).
It is worth of noting that the phospho-p44 MAP kinase, although its
immunoreactivity is relatively less intense than that of phospho-p42
MAP kinase, also shows a time-dependent increase in the WT
mice parallel to that of the phospho-p42 MAP kinase. Again, such an
increase is hardly discernible in the KO mice. These observations
suggest that PKC activation in hippocampal slices of WT mice leads to
activations of both p44 and p42 MAP kinases, and at no time point in KO
mice was stimulation of phospho-MAP kinases meaningfully obtained.
Total MAP kinase levels were unchanged by the above treatments in both
WT and KO mice (Fig. 3A, bottom
panels).
We next analyzed the downstream target of MAP kinases in the
hippocampus. We focused on RSK2, because RSK2 lies immediately downstream of MAP kinase in the phorbol ester- and growth
factor-mediated signaling pathways; additionally, RSK2 has been shown
to be activated by MAP kinase in vitro and in
vivo via phosphorylation. So far, several phosphorylation sites of
RSK2, including Ser-381 (referred to as Ser-380 for the Upstate
Biotechnology antibodies) and Thr-360/Ser-364, have been identified to
be important for its activation (35, 36). Fig.
4 shows that there were
time-dependent increases of phosphorylation of p90RSK at
Ser-381 as well as at Thr-360/Ser-364 in the WT mice during PMA
treatment as analyzed with phosphorylation site-specific anti-p90RSK
antibodies. However, similar exposure of hippocampal slices of Ng KO
mice to PMA caused no appreciable increase of phospho-p90RSK
immunoreactivities.
Transcription factor CREB is a downstream target of MAP kinase in the
hippocampus (15, 22, 24). MAP kinase has been demonstrated previously
to couple to CREB phosphorylation via the intervening RSK kinases in
PC12 cell and neurons (15, 22, 36). RSK2 activates CREB by the
phosphorylation of CREB at Ser-133. As shown in Fig.
5, the application of PMA to hippocampal
slices of WT mice resulted in a robust increase in CREB phosphorylation (2 min, 177 ± 19.4%; 5 min, 194 ± 20.0%; 10 min, 188 ± 18.5%, percentage of control, n = 6). In contrast,
Ng KO mice exhibited a reduced degree of phosphorylation of CREB, a
step that is known to be critical in the formation of long term
memory.
Forskolin Produces Different Kinetics of PKA Activation between WT
and KO Mice--
Under control conditions, cAMP-independent activities
in the hippocampal extracts of both WT and KO mice were, respectively, 11.3 ± 1.5 (n = 7) and 10.7 ± 2.2 (n = 5) pmol/µg of protein/5 min, which corresponded
to 22.6 ± 1.53% (n = 7) and 21.4 ± 2.2% (n = 5), respectively, of total (+cAMP) activities.
Forskolin (50 µM) produced a time-dependent
activation of PKA in hippocampal slices of both WT and KO mice, as
indicated by the increases of activity measured in the absence of cAMP.
The activation in the KO mice was only 50% of that of WT mice (Fig.
6). Although the increase in
cAMP-independent activity in the WT continued until 30 min, it leveled
off only after 10 min of incubation in the KO mice. Thus, the
percentage of independent activity (calculated as percentage of
-cAMP/+cAMP) in KO mice from 10-60 min remained at 30%, whereas, in
WT mice, it was 37.4 ± 7.3% at 10 min, and 42.0 ± 10.0%
from 30 to 60 min.
Forskolin Mediated Different MAP Kinase Cascade Activation between
WT and KO Mice--
It was reported (37, 38) that, in some cell types,
cAMP is coupled positively to MAP kinase activation via Rap-1 and B-Raf and these intermediaries elicit mitogen-activated protein kinase kinase
activation and, subsequently, MAP kinase phosphorylation. In our
experiments, we found that the activation of PKA in hippocampal slices
of WT mice by forskolin resulted in a robust and
time-dependent activations of both p44 and p42 MAP kinases
as analyzed by immunoblotting with
phosphorylation-dependent antibodies (Fig.
7A). Fig. 7B showed the densitometric analysis of the activation of p42 MAP kinase. In WT
mice, 5 min after forskolin treatment, the activation of p42 MAP kinase
was ~1.5-fold, and became almost 2-fold after 10 min and remained
activated until at least 60 min. In contrast, forskolin (50 µM) produced minimal activation of MAP kinase in KO mice
(Fig. 7A). Densitometric analysis indicated that at 10 min
the activation of p42 MAP kinase in KO mice was only 1.25-fold, and
there was no further activation through 60 min of incubation. Again, it
is worth noting (Fig. 7A) that the p44 MAP kinase underwent a degree of activation comparable with those of p42 MAP kinase at least
in the WT mice. It is clear that the total MAPK levels were unchanged
in both WT and KO mice by the above treatments (Fig. 7A,
lower panels).
As shown in Fig. 8, exposure of
hippocampal slices of WT mice to 50 µM forskolin also
caused a time-dependent increase of phospho-p90RSK at
Ser-381 (Ser-380 for Upstate Biotechnology antibodies) and at
Thr-360/Ser-364. At no time point in KO mice did such stimulation of
phospho-p90RSK occur at a significant level.
Many reports (15, 22, 26, 28) indicated that the PKA activity is
important for CREB phosphorylation. As shown in Fig. 9, forskolin caused a significant
increase in CREB phosphorylation in the hippocampal slices of WT mice.
After 10 min of incubation, the CREB phosphorylations in the WT and KO
mice were 190 ± 10.9% versus 104 ± 3.5% of
control (p < 0.01). Although, in WT mice, CREB
phosphorylation was transient and did not remain high throughout 60 min
of incubation, we found that, in KO mice, dephosphorylation of CREB was
already taking place between 30 and 60 min of incubation. Again, the
total CREB level remained unchanged throughout the whole period of
incubation in both WT and KO mice (Fig. 9A,
bottom panels).
In the adult mouse brain, Ng is postnatally expressed at high
levels in the neocortex, hippocampus, and amygdala, brain areas known
to be important for learning and memory in vertebrates (39-41). Although the physiological functions of Ng have not been unequivocally defined, its biochemical properties and postsynaptic localization have
implicated it in several neuronal signal transduction pathways. Recent
work has shown that Ng is phosphorylated in rat hippocampal slices
after the induction of LTP and that intracellular injection of
antibodies against Ng prevents the maintenance phase of LTP (40, 41).
As a result of Ng phosphorylation and/or oxidation, CaM is released
from Ng to form Ca2+/CaM, which could then activate the
Ca2+/CaM-dependent enzymes, including
CaM-dependent kinases, adenylyl cyclases, and NO synthase,
etc., that are involved in the regulation of synaptic plasticity.
Indeed, our previous experiments showed that the Ng KO mice exhibited
severe performance deficits in the Morris water maze. In addition, Ng
KO mice displayed reduced potentiation in hippocampal CA1 with high
frequency stimulation (12),3
as well as a defective mechanism for the autophosphorylation and
activation of CaMKII. All these observations have already suggested to
us that deletion of Ng could affect multifarious signaling pathways.
To understand neural function of Ng in the brain, at the molecular
level, our goal of the present studies was to compare the differences
between WT and KO mice, using the PKC and PKA pathways as upstream
transducers in the activation of MAP kinase cascades. Here we observed
that PMA promoted the translocation of PKC from the cytosolic to the
particulate fractions in both the WT and KO mice. However, the
translocation of PKC activity in the KO mice was much subdued as
compared with that of the WT mice. We also confirmed the observations
by others (15, 16) that PKC activation in the hippocampal CA1 region of
WT mice leads to secondary activation of MAP kinase and the downstream
components of RSK2, and CREB phosphorylations. However, the
phosphorylations and activations of MAP kinase, RSK2, and CREB were
significantly attenuated in the KO as compared with those of WT mice.
It is worth mentioning that, in all our analyses, in contrast to the
other reports (15, 43, 44), p44 MAP kinase was found to be as readily
phosphorylated and activated as p42 MAP kinase, and the time course of
p44 MAP kinase activation paralleled that of p42 MAP kinase (Figs. 3
and 7).
Ng is a prominent PKC substrate (phosphorylation site Ser-36) that
binds CaM in the absence of Ca2+(1, 6, 7, 11). As CaM binds
to Ng through the IQ domain that includes Ser-36, PKC phosphorylation
and CaM binding are mutually exclusive. In resting neurons when
[Ca2+]i is low, Ng may function to
concentrate CaM at specific sites in neurons and release free CaM in
response to increasing Ca2+ and PKC activation. Our data
show that Ng was phosphorylated when hippocampal slices were treated
with PMA (present data) as well as phorbol 12,13-dibutyrate (data not
shown), and it could also be oxidized by sodium nitroprusside and other
NO donors (7, 8, 10). The phosphorylated and oxidized Ng in turn may
lead to an availability of Ca2+/CaM for the activation of
Ca2+/CaM-dependent enzymes at specific sites.
It has also been noted (19, 20) that PKC can activate Raf-1 directly or
indirectly via Ras, then lead to MAP kinase cascades activations. Our
data indicated that the observed decrease in PKC translocation must have contributed in part to a reduced activation of MAP kinase cascades
in the KO mice. In the mean time, the lack of Ng phosphorylation and/or
oxidation, as in the KO mice, would have led to an aberrant regulation
of neuronal Ca2+ and CaM levels, which affect the
activation of Ca2+/CaM-dependent enzymes. In
another word, in the absence of Ng, the fine turning of making
Ca2+/CaM available at the right time and at the right site
is obstructed. Previously, it has been shown that LTP is associated
with an increased phosphorylation of PKC substrates including Ng, and
these phosphorylations can be blocked by PKC inhibitors (39-41). The
attenuated PKC signaling mechanism demonstrated in this study may
explain our previously observed deficits in synaptic plasticity in
these Ng KO mice.
The present data showed that stimulation of the hippocampal slices with
forskolin resulted in a greater activation of PKA in the WT mice as
compared with those of the KO mice. The phosphorylations of the
downstream targets of PKA were significantly attenuated in the KO mice,
which may be largely the result of the reduced PKA activation in these
mice. It was reported that Ca2+/CaM-dependent
form of adenylyl cyclases, namely AC1 and AC8, are enriched in the
hippocampus and are likely responsible for forskolin action (45-47).
Our present experiments with hippocampal slices have clearly
demonstrated this notion that, in the presence of forskolin,
stimulation of such adenylyl cyclases is likely operating to activate
PKA, which is critical for the late phase LTP and long term memory
(47). It is well recognized that phosphorylation of Rap-1 at Ser-179 by
PKA activates B-Raf and then leads to the activation of
mitogen-activated protein kinase kinase and its substrate MAP kinases
(37, 38). Our results suggest that Ng may also plays a role in
controlling PKA activation via
Ca2+/CaM-dependent adenylyl cyclases. All in
all, the data obtained with the Ng KO mice support the hypothesis that
Ng also regulates brain adenylyl cyclases by way of its interactions
with CaM.
CREB is a nuclear protein that modulates the transcription of genes
with cAMP-responsive elements in their promoters. Increase in the
concentration of either Ca2+/CaM or cAMP is found to
trigger the phosphorylation and activation of CREB. Transcription
factor CREB has also been shown to be a downstream target of the MAP
kinase cascade in the hippocampus. Genetic and pharmacological studies
in mice and rats demonstrate that phosphorylation of CREB is required
for the establishment of a variety of complex forms of memory,
including spatial and emotional learning; thus, CREB may be a universal
modulator of processes involved in memory formation (14, 46-48). Our
data indicate that the deficits in the learning and memory of spatial tasks seen in the Ng KO mice may be in part a result of the defects in
the signaling pathways leading to the attenuated phosphorylation of
CREB.
In summary, the current study adds to our growing understanding on the
various deficits in the multifarious signaling pathways in these Ng KO
mice. These results suggest that Ng functions as an upstream modulator
and plays a key role in both the PKC- and PKA-mediated signaling
pathways via its modulation of free Ca2+ and CaM. Both the
PKC and PKA pathways, acting via the regulation of MAP kinases and CREB
phosphorylation, control gene expression required in LTP and other
lasting forms of hippocampal synaptic plasticity. Thus, the attenuation
of CREB phosphorylation in Ng KO mice may be one of the reasons that
result in deficits in hippocampal synaptic plasticity and
hippocampus-dependent spatial learning.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, March 22, 2002, DOI 10.1074/jbc.M109082200
2
J. Wu and F. L. Huang, unpublished data.
3
F. L. Huang, J. Li, J. Wu, and K.-P. Huang,
unpublished data.
The abbreviations used are:
Ng, neurogranin;
PKC, protein kinase C;
PKA, protein kinase A;
CaM, calmodulin;
KO, knockout;
WT, wild type;
PMA, phorbol 12-myristate 13-acetate;
ACSF, artificial cerebrospinal fluid;
MAP, mitogen-activated protein;
RSK2, 90-kDa ribosomal S6 kinase;
CREB, cAMP response element-binding
protein;
CaMKII, Ca2+/CaM-dependent protein
kinase II;
LTP, long term potentiation;
TTBS, Tris-buffered
saline with Tween 20;
S, cytosolic;
P, particulate membrane.
Attenuation of Protein Kinase C and cAMP-dependent
Protein Kinase Signal Transduction in the Neurogranin Knockout
Mouse*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP,
PerkinElmer Life Sciences; AG 1-X8 resin, protein assay reagent,
and horseradish peroxidase-conjugated goat anti-rabbit IgG and goat
anti-mouse IgG, Bio-Rad; phosphatidylserine and 1,2-dioleoylglycerol, Avanti Polar Lipids; and bovine serum albumin and cAMP, Sigma.
70 °C until processing.
Each sample was sonicated in Homogenization Buffer (50 mM
Tris-Cl, pH 7.5, containing 2 mM dithiothreitol, 2 mM EDTA, 1 mM EGTA, 50 µM
4-(2-aminoethyl)-benzenesulfonylfluoride hydrochloride, 5 mg/ml
leupeptin, 50 mM KF, 50 nM okadaic acid, and
1% SDS), and the clear homogenate used for protein determination and
immunoblot analysis. Control experiments where slices were left
untreated or mock-treated with carrier ACSF were also carried out.
These samples, when analyzed by immunoblot with various antibodies, did
not produce any changes in the states of phosphorylation over the
period of incubation.
-32P]ATP, 1.0 mg/ml bovine serum
albumin, 20 µM Ng-(28-43) peptide substrate, 0.1 mg/ml
phosphatidylserine, 0.02 mg/ml 1,2-dioleoylglycerol, 0.4 mM
CaCl2 or 1.5 mM EGTA, and 1 µg protein of
tissue extract. Reactions were stopped with 100 µl of ice-cold 20%
trichloroacetic acid containing 50 mM ATP. After standing
in ice for 10 min, the mixture was centrifuged, and the supernatant
passed through a minicolumn (0.5 ml) of AG 1-X8 resin in acetate form.
The column was washed twice each with 1 ml of 30% acetic acid.
32P-Labeled peptide substrates eluted were measured in a
scintillation counter. All reactions were run in duplicate; PKC
activities were expressed as picomoles of 32P incorporated
into peptide/µg of protein/5 min.
-32P]ATP, 1.0 mg/ml bovine serum
albumin, 40 µM Kemptide, with or without 10 µM cAMP, and 1 µg protein of tissue extract. Reactions were stopped, and 32P incorporation into peptide was
determined as described for PKC activity measurement. All reactions
were run in duplicate. PKA activities were expressed as picomoles of
32P incorporated into peptide substrate/µg of protein/5
min. Activities measured with cAMP were considered as total PKA
activity, which remained near constant throughout the incubation period
whereas activities measured without cAMP increased following forskolin treatment as a result of elevated level of cAMP. Thus, increase in
-cAMP activities calculated as percentage of total activity (+cAMP)
was used as an index of PKA activation. Kinase assay in the presence of
synthetic PKA inhibitor peptide (residues 5-22), abolished near
completely the cAMP-activated activity and the increase in the
cAMP
activity resulting from forskolin treatment.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (49K):
[in a new window]
Fig. 1.
PMA-mediated activation of PKC in hippocampal
slices. Hippocampal slices from adult WT and KO mice brains
(400-µm thickness) were incubated with ACSF at room temperature under
5% CO2, 95% O2 atmosphere with 4 µM PMA for the indicated times. Homogenization and
centrifugation of the hippocampal slices to yield the cytosolic (S) and
particulate membrane fractions (P) were described in detail under
"Experimental Procedures." A, immunoblot analyses with
anti-conventional PKC antibodies, where 20 µg of proteins from the
cytosolic and particulate fractions were separated by SDS-PAGE (8%
gel). B, PKC activities in the cytosolic and particulate
membrane fractions were determined using Ng peptide (residues 28-43)
as substrate. The control PKC activities were, respectively, 188 ± 27.4 (WT, S), 173 ± 9.3 (KO, S), 155 ± 11.8 (WT, P), and
145 ± 10.0 (KO, P) pmol/µg of protein/5 min. The data represent
means ±S.E. of seven WT and four KO separate experiments. *,
p < 0.05 is WT versus KO groups.

View larger version (36K):
[in a new window]
Fig. 2.
PMA-induced Ng phosphorylation in hippocampal
slices of WT mice. Hippocampal slices from adult WT mice brains
were incubated with 4 µM PMA as described in Fig 1. At
timed intervals, hippocampal slices were removed, washed and kept
frozen at
70 °C, and were homogenized with homogenization buffer
containing 1% SDS as described under "Experimental Procedures."
A, immunoblot analyses with phospho-Ng and total Ng
antibody. Proteins of 20 µg were separated by SDS-PAGE (10-20%
gradient gel). Antibody 3615, which is specific for the phosphorylated
form of Ng, was used for the detection of phospho-Ng, and antibody 270 for the detection of total Ng. B, quantification of
phospho-Ng immunoreactivities. Relative intensities were measured and
expressed as percentage of basal level; values are means ± S.E.
of six independent experiments of WT mice. ***, p < 0.001 versus zero time.

View larger version (43K):
[in a new window]
Fig. 3.
PMA-stimulated phosphorylation of MAP
kinases. Hippocampal slices from adult WT and KO mice brains were
incubated with 4 µM PMA as described in Fig 1. At timed
intervals, hippocampal slices were kept frozen at
70 °C after
incubation and homogenized as described in Fig. 2. A,
immunoblot analyses with anti-phospho-MAP kinases (top
panels) and anti-MAP kinases (lower
panels) antibodies. Proteins of 30 µg were separated by
SDS-PAGE (10% gel). B, quantification of phospho-p42 MAP
kinase immunoreactivities. Relative intensities were measured and
expressed as percentage of control; values are means ± S.E. of
three (KO) and six (WT) independent experiments. *, p < 0.05 is WT versus KO groups.

View larger version (45K):
[in a new window]
Fig. 4.
Phosphorylation of p90 RSK during PMA
treatment. Hippocampal slices from adult WT and KO mice brains
were incubated with 4 µM PMA for the indicated times as
described in Fig 1. Hippocampal slices were kept frozen at
70 °C
after incubation and homogenized as described in Fig. 2. A,
immunoblot analyses with anti-phospho-p90 RSK (Ser-380, left
panels; Thr-360/Ser-364, right panels)
antibodies. Samples represent 30 µg of proteins and were separated by
SDS-PAGE (10% gel). B, quantification of phospho-p90 RSK
immunoreactivities. Relative intensities are expressed as percentage of
control and they are means ± S.E. of three (KO) and five (WT)
independent experiments. *, p < 0.05; **,
p < 0.01, ***, p < 0.001 are WT
versus KO groups.

View larger version (41K):
[in a new window]
Fig. 5.
Phosphorylation of CREB in PMA-treated
hippocampal slices. Hippocampal slices from adult WT and KO mice
brains were incubated with 4 µM PMA. At timed intervals,
hippocampal slices were taken and kept frozen at
70 °C and
homogenized as in Fig. 2. Proteins of 30 µg were analyzed by
immunoblotting with a phosphospecific antibody that only recognizes
phosphorylated (Ser-133) CREB. After ECL reactions, the membranes were
stripped in buffer containing 2% SDS and 100 mM
2-mercaptoethanol before re-probing with the antibody that recognizes
CREB. A, representative immunoblots showing phospho-CREB
(top panels) and total CREB (lower
panels) immunoreactivities. B, quantification of
phospho-CREB immunoreactivities. Relative intensities are expressed as
percentage of control, and they are means ± S.E. of three (KO)
and six (WT) independent experiments. *, p < 0.05 is
WT versus KO groups.

View larger version (19K):
[in a new window]
Fig. 6.
Forskolin-mediated activation of PKA.
Hippocampal slices from adult WT and KO mice brains were incubated with
50 µM forskolin for the indicated times as described
under "Experimental Procedures." Hippocampal slices were taken and
kept frozen at
70 °C after incubation. Proteins were extracted
with homogenization buffer containing 0.1% Nonidet P-40 and were used
for the measurement of PKA activity using Kemptide in the presence and
absence of 10 µM cAMP. Percentage of cAMP-independent
activities were determined. The control
cAMP activities were
11.3 ± 1.5 (WT, n = 7) and 10.7 ± 2.2 (KO,
n = 5) pmol/µg of protein/5 min, which corresponded,
respectively, to 22.6 ± 1.53% (n = 7) and
21.4 ± 2.2% (n = 5) of total (+cAMP) activities.
The data represent means ±S.E. of five (WT) and seven (KO) separate
experiments. *, p < 0.05 is WT versus KO
groups.

View larger version (42K):
[in a new window]
Fig. 7.
Forskolin-stimulated phosphorylation of MAP
kinases. Hippocampal slices from adult WT and KO mice brains were
incubated with 50 µM forskolin. At timed intervals,
hippocampal slices were taken and kept frozen at
70 °C and
homogenized with homogenization buffer containing 1% SDS.
A, immunoblot analyses with anti-phospho-MAP kinase
(top panels) and anti-MAP kinase
(lower panels) antibodies. Each lane contains 30 µg of protein, which were separated by SDS-PAGE (10% gel).
B, quantification of phospho-p42 MAP kinase
immunoreactivities. Relative intensities are expressed as percentage of
control, and they are means ± S.E. of three (KO) and six (WT)
independent experiments. **, p < 0.01; ***,
p < 0.001 are WT versus KO groups.

View larger version (43K):
[in a new window]
Fig. 8.
Phosphorylation of p90 RSK during forskolin
treatment. Hippocampal slices from adult WT and KO mice brains
were incubated with 50 µM forskolin for the indicated
times. Hippocampal slices were kept frozen at
70 °C after
incubation and homogenized as in Fig. 2. A, immunoblot
analyses with anti-phospho-p90 RSK (Ser-380, left
panels; Thr-360/Ser-364, right panels)
antibodies. Samples were of equal amounts of proteins (30 µg) and
were separated by SDS-PAGE (10% gel). B, quantification of
phospho-p90 RSK immunoreactivities. Relative intensities are expressed
as percentage of control and are means ± S.E. of three (KO) and
six (WT) independent experiments. *, p < 0.05; **,
p < 0.01 are WT versus KO groups.

View larger version (43K):
[in a new window]
Fig. 9.
Phosphorylation of CREB in forskolin-treated
hippocampal slices. Hippocampal slices from adult WT and KO mice
brains were incubated with 50 µM forskolin. At timed
intervals, hippocampal slices were taken and kept frozen at
70 °C
and homogenized as described in Fig. 2. Proteins (30 µg) were
analyzed by immunoblotting with a phosphospecific antibody that only
recognizes phosphorylated (Ser-133) CREB. After ECL reaction, the
membranes were stripped and re-probed with an antibody that recognizes
CREB as described in Fig. 5. A, representative immunoblot
analysis of phospho-CREB (top panels) and total
CREB (lower panels). B, quantification
of phospho-CREB immunoreactivities. Relative intensities are expressed
as percentage of control and are means ± S.E. of three (KO) and
six (WT) independent experiments. *, p < 0.05; **,
p < 0.01 are WT versus KO groups
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 301-496-1093;
E-mail: fhuang@helix.nih.gov.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Gerendasy, D. D.,
and Sutcliffe, J. G.
(1997)
Mol. Neurobiol.
15,
131-163[Medline]
[Order article via Infotrieve]
2.
Repressa, A.,
Deloulme, J. C.,
Sensenbrenner, M.,
Ben-Ari, Y.,
and Baudier, J.
(1990)
J. Neurosci.
10,
3782-3792[Abstract]
3.
Watson, J. B.,
Sutcliffe, J. G.,
and Fisher, R. S.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
8581-8585 4.
Watson, J. B.,
Szijan, I.,
and Coulter, P. M.
(1994)
Mol. Brain Res.
27,
323-328[Medline]
[Order article via Infotrieve]
5.
Neuner-Jehle, M.,
Denizot, J.-P.,
and Mallet, J.
(1996)
Brain Res.
733,
149-154[Medline]
[Order article via Infotrieve]
6.
Huang, K.-P.,
Huang, F. L.,
and Chen, H.-C.
(1993)
Arch. Biochem. Biophys.
305,
570-580[CrossRef][Medline]
[Order article via Infotrieve]
7.
Sheu, F.-S.,
Mahoney, C. W.,
Seki, K.,
and Huang, K.-P.
(1996)
J. Biol. Chem.
271,
22407-22413 8.
Li, J.,
Pak, J. H.,
Huang, F. L.,
and Huang, K.-P.
(1999)
J. Biol. Chem.
274,
1294-1300 9.
Miao, H. H., Ye, J. S.,
Wong, S. L.,
Wang, B. X., Li, X. Y.,
and Sheu, F. S.
(2000)
Bioelectrochemistry
51,
163-173[CrossRef][Medline]
[Order article via Infotrieve]
10.
Mahoney, C. W.,
Pak, J. H.,
and Huang, K.-P.
(1996)
J. Biol. Chem.
271,
28798-28804 11.
Prichard, L.,
Deloulme, J. C.,
and Storm, D. R.
(1999)
J. Biol. Chem.
274,
7689-7694 12.
Pak, J. H.,
Huang, F. L., Li, J.,
Balschun, D.,
Reymann, K. G.,
Chiang, C.,
Westphal, H.,
and Huang, K.-P.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11232-11237 13.
Giese, K. P.,
Fedorov, N. B.,
Filipkowski, R. K.,
and Silva, A. J.
(1998)
Science
279,
870-873 14.
Silva, A. J.,
Kogan, J. H.,
Frankland, P. W.,
and Kida, S.
(1998)
Annu. Rev. Neurosci.
21,
127-148[CrossRef][Medline]
[Order article via Infotrieve]
15.
Roberson, E. D.,
English, J. D.,
Adams, J. P.,
Selcher, J. C.,
Kondratick, C.,
and Sweatt, J. D.
(1999)
J. Neurosci.
19,
4337-4348 16.
Sweatt, J. D.
(2001)
J. Neurochem.
76,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
17.
Villacres, E. C.,
Wong, S. T.,
Chavkin, C.,
and Storm, D. R.
(1998)
J. Neurosci.
18,
3186-3194 18.
Miyasaka, T.,
Miyasaka, J.,
and Saltiel, A. R.
(1990)
Biochem. Biophys. Res. Commun.
168,
1237-1243[CrossRef][Medline]
[Order article via Infotrieve]
19.
Posada, J.,
and Cooper, J. A.
(1992)
Science
255,
212-215 20.
Seger, R.,
and Krebs, E. G.
(1995)
FASEB J.
9,
726-735[Abstract]
21.
Atkins, C. M.,
Selcher, J. C.,
Petraitis, J. J.,
Trzaskos, J. M.,
and Sweatt, J. D.
(1998)
Nat. Neurosci.
1,
602-609[CrossRef][Medline]
[Order article via Infotrieve]
22.
Impey, S.,
Obrietan, K.,
Wong, S. T.,
Poser, S.,
Yano, S.,
Wayman, G.,
Deloulme, J. C.,
Chan, G.,
and Storm, D. R.
(1998)
Neuron
21,
869-883[CrossRef][Medline]
[Order article via Infotrieve]
23.
Impey, S.,
Obrietan, K.,
and Storm, D. R.
(1999)
Neuron
23,
11-14[CrossRef][Medline]
[Order article via Infotrieve]
24.
Huang, Y. Y.,
Martin, K. C.,
and Kandel, E. R.
(2000)
J. Neurosci.
20,
6317-6325 25.
Giovannini, M. G.,
Blitzer, R. D.,
Wong, T.,
Asoma, K.,
Tsokas, P.,
Morrison, J. H.,
Iyengar, R.,
and Landau, E. M.
(2001)
J. Neurosci.
21,
7053-7062 26.
Crow, T.,
Xue-Bian, J. J.,
Siddiqi, V.,
and Neary, J. T.
(2001)
J. Neurochem.
78,
358-364[CrossRef][Medline]
[Order article via Infotrieve]
27.
Blum, S.,
Moore, A. N.,
Adams, F.,
and Dash, P. K.
(1999)
J. Neurosci.
19,
3535-3544 28.
Zanassi, P.,
Paolillo, M.,
Feliciello, A.,
Avvedimento, E. V.,
Gallo, V.,
and Schinelli, S.
(2001)
J. Biol. Chem.
276,
11487-11495 29.
Xing, J.,
Ginty, D. D.,
and Greenberg, M. E.
(1996)
Science
273,
959-963[Abstract]
30.
Huang, K.-P.,
Huang, F. L.,
Nakabayashi, H.,
and Yoshida, Y.
(1988)
J. Biol. Chem.
263,
14839-14845 31.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
32.
Huang, K.-P.,
Nakabayashi, H.,
and Huang, F. L.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8535-8539 33.
Lo, L. W.,
Cheng, J. J.,
Chiu, J. J.,
Wung, B. S.,
Liu, Y. C.,
and Wang, D. L.
(2001)
J. Cell. Physiol.
188,
304-312[CrossRef][Medline]
[Order article via Infotrieve]
34.
Bapat, S.,
Verkleij, A,
and Post, J. A.
(2001)
FEBS Lett.
499,
21-26[CrossRef][Medline]
[Order article via Infotrieve]
35.
Dalby, K. N.,
Morrice, N.,
Caudwell, F. B.,
Avruch, J.,
and Cohen, P.
(1998)
J. Biol. Chem.
273,
1496-1505 36.
Zhang, Y.,
Zhong, S.,
Dong, Z.,
Chen, N.,
Bode, A. M., Ma, W.,
and Dong, Z.
(2001)
J. Biol. Chem.
276,
14572-14580 37.
Vossler, M. R.,
Yao, H.,
York, R. D.,
Pan, M.-G.,
Rim, C. S.,
and Stork, P. J. S.
(1997)
Cell
89,
73-82[CrossRef][Medline]
[Order article via Infotrieve]
38.
Kawasaki, H.,
Springett, G. M.,
Mochizuki, N.,
Toki, S.,
Nakaya, M.,
Matsuda, M.,
Housman, D. E.,
and Graybiel, A. M.
(1998)
Science
282,
2275-2279 39.
Klann, E.,
Chen, S.-J.,
and Sweatt, J. D.
(1992)
J. Neurochem.
58,
1576-1579[CrossRef][Medline]
[Order article via Infotrieve]
40.
Ramakers, G. M. J., De,
Graan, P. N. E.,
Urban, I. J. A.,
Kraay, D.,
Tang, T.,
Pasinelli, P.,
Oestricher, A. B.,
and Gispen, W. H.
(1995)
J. Biol. Chem.
270,
13892-13898 41.
Fedorov, N. B.,
Pasinelli, P.,
Oestricher, A. B., De,
Graan, P. N. E.,
and Reymann, K. G.
(1995)
Eur. J. Neurosci.
7,
819-822[CrossRef][Medline]
[Order article via Infotrieve]
42.
Martzen, M. R.,
and Slemmon, J. R.
(1995)
J. Neurochem.
64,
92-100[Medline]
[Order article via Infotrieve]
43.
English, J. D.,
and Sweatt, J. D.
(1996)
J. Neurosci.
271,
24329-24332
44.
Fiore, R. S.,
Murphy, T. H.,
Sanghera, J. S.,
Pelech, S. L.,
and Baraban, J. M.
(1993)
J. Neurochem.
61,
1626-1633[Medline]
[Order article via Infotrieve]
45.
Chetkovich, D. M.,
and Sweatt, J. D.
(1993)
J. Neurochem.
61,
1933-1942[Medline]
[Order article via Infotrieve]
46.
Tang, W.-J.,
and Hurley, J. H.
(1998)
Mol. Pharmacol.
54,
231-240 47.
Wong, S. T.,
Athos, J.,
Figueroa, X. A.,
Pineda, V. V.,
Schaefer, M. L.,
Chavkin, C. C.,
Muglia, L. J.,
and Storm, D. R.
(1999)
Neuron
23,
787-798[CrossRef][Medline]
[Order article via Infotrieve]
48.
Viola, H.,
Furman, M.,
Izquierdo, L. A. I.,
Alonso, M.,
Barros, D. M.,
de Souza, M. M.,
Izquierdo, I.,
and Medina, J. H.
(2000)
J. Neurosci.
20,
1-5
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. A. Putkey, M. N. Waxham, T. R. Gaertner, K. J. Brewer, M. Goldsmith, Y. Kubota, and Q. K. Kleerekoper Acidic/IQ Motif Regulator of Calmodulin J. Biol. Chem., January 18, 2008; 283(3): 1401 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Huang, K.-P. Huang, and C. Boucheron Long-term enrichment enhances the cognitive behavior of the aging neurogranin null mice without affecting their hippocampal LTP Learn. Mem., August 1, 2007; 14(8): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Huang, K.-P. Huang, J. Wu, and C. Boucheron Environmental enrichment enhances neurogranin expression and hippocampal learning and memory but fails to rescue the impairments of neurogranin null mutant mice. J. Neurosci., June 7, 2006; 26(23): 6230 - 6237. [Abstract] |